Medtronic Return on Tangible Equity 2010-2025 | MDT

Current and historical return on tangible equity values for Medtronic (MDT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Medtronic Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-04-30 $4.66B $-5.15B -97.39%
2025-01-31 $4.26B $-3.39B -95.78%
2024-10-31 $4.29B $-4.87B -99.40%
2024-07-31 $3.93B $-5.74B -100.55%
2024-04-30 $3.68B $-3.79B -102.23%
2024-01-31 $4.20B $-2.85B -110.61%
2023-10-31 $4.10B $-3.23B -93.47%
2023-07-31 $3.62B $-4.50B -78.97%
2023-04-30 $3.76B $-4.60B -87.97%
2023-01-31 $4.06B $-5.21B -102.48%
2022-10-31 $4.32B $-4.02B -112.54%
2022-07-31 $5.21B $-3.26B -120.22%
2022-04-30 $5.04B $-3.38B -95.95%
2022-01-31 $4.91B $-4.71B -76.39%
2021-10-31 $4.70B $-5.98B -61.75%
2021-07-31 $3.88B $-6.95B -45.93%
2021-04-30 $3.61B $-8.10B -40.29%
2021-01-31 $2.89B $-9.45B -32.37%
2020-10-31 $3.54B $-9.31B -41.77%
2020-07-31 $4.41B $-8.94B -52.56%
2020-04-30 $4.79B $-8.03B -55.60%
2020-01-31 $5.32B $-7.59B -57.88%
2019-10-31 $4.67B $-9.01B -46.65%
2019-07-31 $4.42B $-9.82B -43.40%
2019-04-30 $4.63B $-10.31B -45.39%
2019-01-31 $4.92B $-10.90B -48.05%
2018-10-31 $2.26B $-9.71B -21.70%
2018-07-31 $3.16B $-9.90B -30.05%
2018-04-30 $3.10B $-10.44B -28.47%
2018-01-31 $2.81B $-11.63B -25.08%
2017-10-31 $5.02B $-10.12B -39.29%
2017-07-31 $4.12B $-11.42B -27.85%
2017-04-30 $4.03B $-11.59B -24.96%
2017-01-31 $3.97B $-17.94B -22.91%
2016-10-31 $4.24B $-18.15B -24.87%
2016-07-31 $3.65B $-16.85B -21.84%
2016-04-30 $3.54B $-16.34B -21.61%
2016-01-31 $2.43B $-16.88B -15.08%
2015-10-31 $2.32B $-16.74B -22.71%
2015-07-31 $2.62B $-15.55B -58.03%
2015-04-30 $2.68B $-15.40B 291.47%
2015-01-31 $3.12B $6.88B 48.74%
2014-10-31 $2.91B $5.98B 46.28%
2014-07-31 $2.98B $6.21B 48.04%
2014-04-30 $3.07B $6.56B 50.68%
2014-01-31 $3.59B $6.39B 61.57%
2013-10-31 $3.81B $5.67B 70.45%
2013-07-31 $3.56B $5.57B 68.71%
2013-04-30 $3.47B $5.67B 69.69%
2013-01-31 $3.49B $4.74B 74.36%
2012-10-31 $3.44B $4.73B 74.00%
2012-07-31 $3.66B $4.76B 82.45%
2012-04-30 $3.62B $4.53B 84.62%
2012-01-31 $3.40B $4.54B 83.57%
2011-10-31 $3.39B $3.92B 91.56%
2011-07-31 $3.09B $4.10B 85.00%
2011-04-30 $3.10B $3.72B 87.71%
2011-01-31 $3.28B $3.07B 93.07%
2010-10-31 $3.18B $3.63B 85.98%
2010-07-31 $3.48B $3.70B 98.22%
2010-04-30 $3.10B $3.68B 95.34%
2010-01-31 $2.25B $3.80B 75.92%
2009-10-31 $2.11B $3.01B 75.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $118.558B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $222.716B 26.12
Boston Scientific (BSX) United States $157.517B 37.62
Stryker (SYK) United States $152.893B 31.97
EssilorLuxottica (ESLOY) France $140.240B 0.00
Lonza Group Ag (LZAGY) Switzerland $50.586B 0.00
Haleon (HLN) United Kingdom $44.070B 25.15
ResMed (RMD) United States $40.718B 30.58
GE HealthCare Technologies (GEHC) United States $35.587B 16.90
Agilent Technologies (A) United States $34.042B 22.19
Koninklijke Philips (PHG) Netherlands $26.981B 17.85
Terumo (TRUMY) Japan $25.673B 33.35
Insulet (PODD) United States $20.514B 80.52
Zimmer Biomet Holdings (ZBH) United States $18.786B 12.06
Baxter (BAX) United States $14.800B 11.05
Smith & Nephew SNATS (SNN) United Kingdom $13.840B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.874B 23.92
Lantheus Holdings (LNTH) United States $4.995B 12.60
Perrigo (PRGO) Ireland $3.859B 9.78
Prestige Consumer Healthcare (PBH) United States $3.689B 16.48
Haemonetics (HAE) United States $3.629B 16.53
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.441B 28.59
ICU Medical (ICUI) United States $3.119B 23.00
LeMaitre Vascular (LMAT) United States $1.863B 41.64
QuidelOrtho (QDEL) United States $1.720B 11.83
AtriCure (ATRC) United States $1.571B 0.00
Acuren (TIC) United States $1.369B 0.00
Green Thumb Industries (GTBIF) United States $1.272B 28.62
AdaptHealth (AHCO) United States $1.259B 12.78
Phibro Animal Health (PAHC) United States $1.135B 14.51
BioLife Solutions (BLFS) United States $1.057B 0.00
Neogen (NEOG) United States $1.048B 16.66
Curaleaf Holdings (CURLF) Canada $0.933B 0.00
InMode (INMD) Israel $0.905B 9.11
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Valneva SE (VALN) France $0.660B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.632B 0.00
Evolus (EOLS) United States $0.596B 0.00
Tilray Brands (TLRY) Canada $0.581B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Surmodics (SRDX) United States $0.535B 0.00
CeriBell (CBLL) United States $0.533B 0.00
ZimVie (ZIMV) United States $0.524B 23.81
SNDL (SNDL) Canada $0.384B 0.00
VAREX IMAGING (VREX) United States $0.322B 11.83
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Capricor Therapeutics (CAPR) United States $0.308B 0.00
Quanterix (QTRX) United States $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Cresco Labs (CRLBF) United States $0.295B 0.00
Cerus (CERS) United States $0.254B 0.00
Aurora Cannabis (ACB) Canada $0.250B 74.00
Biote (BTMD) United States $0.249B 7.00
Viemed Healthcare (VMD) United States $0.247B 20.87
Omeros (OMER) United States $0.245B 0.00
OraSure Technologies (OSUR) United States $0.245B 0.00
Brainsway (BWAY) Israel $0.224B 59.15
Sanara MedTech (SMTI) United States $0.222B 0.00
Verano Holdings (VRNOF) United States $0.217B 0.00
Canopy Growth (CGC) Canada $0.209B 0.00
Organigram Global (OGI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.09
Exagen (XGN) United States $0.180B 0.00
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
TerrAscend (TSNDF) Canada $0.132B 0.00
FitLife Brands (FTLF) United States $0.123B 15.18
Jushi Holdings (JUSHF) United States $0.107B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.099B 12.74
Quipt Home Medical (QIPT) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
Veru (VERU) United States $0.072B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.92
Nephros (NEPH) United States $0.037B 49.57
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00